Baxter Healthcare has issued an urgent U.S. recall of nine lots of the injectable blood thinner heparin after reports of adverse patient reactions.
The recall includes heparin sodium injection in 1,000 Units/mL, 10 mL and 30mL multi-dose vials with lot number. The lot numbers are 107054, 117085, 047056, 097081, 107024, 107064, 107066, 107074 and 107111
The company said it issued the recall as a precautionary measure while it investigates the cause of allergic-type reactions that include stomach pain or discomfort, nausea, vomiting, diarrhea, decreased or low blood pressure, chest pain, fast heart rate, dizziness, fainting, unresponsiveness and shortness of breath.
The 1,000 units/mL multi-dose vials are primarily used for hemodialysis and cardiac invasive procedures, the company said.
Copyright 2008 by United Press International
Explore further: AbbVie shares sink after $21 bn deal for Pharmacyclics